{"id":"W2177483322","doi":"10.1139/cjpp-2013-0488","title":"Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases","year":2014,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Angiotensin-converting enzyme 2; Heart failure; Angiotensin II; Renin–angiotensin system; Receptor; Medicine; Internal medicine; Endocrinology; Fibrosis; Angiotensin II receptor type 1; Vasodilation; Angiotensin 1; Angiotensin-converting enzyme; Muscle hypertrophy; Inflammation; Pharmacology; Blood pressure; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003436885,0.0005873176,0.001147141,0.002082402,0.0002271148,0.000681237,0.0006009893,0.0007814509,0.003659948],"category_scores_gemma":[0.0004037041,0.00017912,0.0004982667,0.001674454,0.0002862238,0.0009957966,0.0004537349,0.001508404,0.001365478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004687101,"about_ca_system_score_gemma":0.0009191008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008701058,"about_ca_topic_score_gemma":0.002144885,"domain_scores_codex":[0.9998653,0.000021269,0.00001971023,0.00002094584,0.00005848843,0.00001423643],"domain_scores_gemma":[0.9998413,0.00006757648,0.00002126459,0.00000421876,0.00004878346,0.00001690047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009609831,0.0001241073,0.0001951331,0.02582612,0.0001432186,0.000354174,0.00009387175,0.0003000566,0.00387373,0.003850037,0.02921659,0.9359269],"study_design_scores_gemma":[0.00003144721,0.0001288236,0.0009887984,0.00400116,0.0001952945,0.001691891,0.00006995865,0.00009362902,0.00066299,0.00166345,0.9904545,0.00001783887],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000120095,0.9988065,0.0000774939,0.000192326,0.0001344638,0.000003192819,0.00001009614,0.000004608797,0.0006512094],"genre_scores_gemma":[0.0006613252,0.9985377,0.0001453293,0.0001387878,0.0001059987,0.000003951292,0.00001809091,8.841237e-7,0.0003880096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003659948,"threshold_uncertainty_score":0.01224369,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03494342495620185,"score_gpt":0.3262150511843768,"score_spread":0.291271626228175,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}